De Ceunynck Radiotherapy
ActiveFrom the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
The computed 12-month bankruptcy probability of De Ceunynck Radiotherapy is 5.8% (elevated). The 2025 annual accounts show negative equity (-€2.0m) and a net result of -€446,329. Equity has been shrinking by about 48% per year since 2018. Its solvency ranks better than 5% of 94 sector peers (NACE 21, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
KBO- Status
- Active since 28-08-2017 Normal situation
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21209and 4 others
- Establishment unit
- 2.267.531.485 2630 Aartselaar, since 28-08-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 14-11-2025
Board and ownership
- Peter DejongeManaging director
- Bettesone PhilippeDirector · since 01-01-2026
- De Ceunynck ErikDirector
Financial position
- Bankruptcy probabilitywithin 12 months
- 5.8%
- Gross margin
- -€33,632
- Loss
- €446,329
- ▲ 11.5%
- Equity
- -€2.0m
- ▼ 27.9%
- Total assets
- €477,215
- ▼ 24.9%
- Staff
- 2 FTE
- ▼ 20.0%
Score breakdownraises riskLoss of €446,329, the second in a row (financial year 2025)Negative equity -€2.0mLast filed accounts filed 91 days late; 2 of the last 3 accounts lateFigures for financial year 2025 (filed on 30-10-2026)Show the evidence
Checked score
About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro). It does better than 10% of them on solvency, 15% on liquidity, 13% on profitability and 25% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 135 days after the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€2.0m View
- Risk: 3 loss-making years in a rowloss in financial year 2025 -€446,329 View
- Caution: Lower solvency than 95% of companies in pharmaceuticalssector median 48.2% · 94 companies -428.8% View
- Caution: Equity fell in 2025from -€1.6m to -€2.0m ▼ 27.9% View
- New directorlatest change 01-01-2026 · 3 in office 1 joined View
Comparable companies
These companies have the same main activity as De Ceunynck Radiotherapy: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209). They are comparable in size and age: total assets between €58,500 and €503,000, founded between 1998 and 2024.
| Company | Total assets | Gross margin |
|---|---|---|
| De Ceunynck Radiotherapy Aartselaar | €477,215 | -€33,632 |
| Highstar Engineering Diepenbeek | €342,212 | -€52,153 |
| HONEYPATCH Liège | €330,409 | -€5,116 |
| Asterion Therapeutics Beveren-Kruibeke-Zwijndrecht | €58,464 | -€15,448 |
| NEIRYNCK en VOGT Schelle | €310,017 | €5,000 |
| THAMEUS Liège | €502,659 | -€119,888 |
| AdipoPharma Belgique Charleroi | €398,195 | €514 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 30-10-2026
- Annual accounts 2024filed on 29-08-2025
- Annual accounts 2023filed on 03-07-2025
- Annual accounts 2022filed on 03-04-2024
Acts in the Belgian Official Gazette
- Resignations & appointmentsact of 29-11-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about De Ceunynck Radiotherapy
- What is the company number of De Ceunynck Radiotherapy?
- The company number of De Ceunynck Radiotherapy is 0680.604.062. The VAT number is the same number with BE in front: BE 0680.604.062.
- Where is De Ceunynck Radiotherapy based?
- The registered office is at Kontichsesteenweg 36, 2630 Aartselaar.Company details
- What does De Ceunynck Radiotherapy do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
- What is the legal form of De Ceunynck Radiotherapy?
- The legal form of De Ceunynck Radiotherapy is Public limited company (NV).
- When was De Ceunynck Radiotherapy founded?
- De Ceunynck Radiotherapy was founded on 28-08-2017.
- Is De Ceunynck Radiotherapy still active?
- Yes, De Ceunynck Radiotherapy is an active enterprise in the KBO register.
- How many employees does De Ceunynck Radiotherapy have?
- De Ceunynck Radiotherapy had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of De Ceunynck Radiotherapy?
- The annual accounts for financial year 2025 state no turnover.
- Is De Ceunynck Radiotherapy profitable?
- In financial year 2025, De Ceunynck Radiotherapy made a loss of €446,329.
- Where can I find the annual accounts of De Ceunynck Radiotherapy?
- De Ceunynck Radiotherapy filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
- When are the next annual accounts of De Ceunynck Radiotherapy due?
- De Ceunynck Radiotherapy must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.